About Us

LABTER PHARMATECH CO.,LTD was established at the end of 2014, with its business address located at Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing. Main business: screening and synthesis of active block molecules, development and sales of new pharmaceutical intermediates, and development and sales of new material intermediates. The company is mainly engaged in the design and synthesis of molecular libraries for pharmaceutical raw materials, cyclic small molecules (such as ninhydrin, naphthalene ketone, chromogenic ketone, etc.), chiral amines, chiral amino alcohols, chiral amino acids and their non natural derivatives, as well as the technological development of new material intermediates.
The company has long adhered to the implementation of product research and development innovation strategy, and has established a research and development center since its establishment. It has been 9 years since then. There are over 20 researchers in the R&D center, with approximately 70% having a bachelor's degree or above. Senior researchers account for 60% and research assistants account for 40%, with rich professional experience. The experimental research and development center covers an area of approximately 1000 square meters and is equipped with conventional organic synthesis and analysis equipment. It can conduct chemical reactions in small quantities up to 100 liters of pilot scale, and can provide research and development and production of products in the range of grams to kilograms. The company has established a comprehensive research and development system, including a project management system and a risk management system. Significant breakthroughs have been made in independent innovation. At present, the company has applied for 4 domestic invention patents, including 1 authorized patent and 3 pending applications; Apply for 4 utility model patents, all of which have been authorized.
The research and development center focuses on the asymmetric synthesis and separation of chiral amine compounds; Metal cross coupling of non natural chiral amino acid compounds; Synthesis of some heterocyclic compounds. The company has accumulated rich experience in synthesis and purification through years of research and development, and can quickly and efficiently obtain target compounds.